The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

19 Feb 2021 07:01

RNS Number : 6530P
Kingspan Group PLC
19 February 2021
 

 

Kingspan Group Plc

 

Director Appointments

 

19 February 2021

 

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce the appointments of Éimear Moloney as an Independent Non-Executive Director and Paul Murtagh as a Non-Executive Director with effect from 30 April 2021.

 

Éimear (50) was previously a senior investment manager in Zurich Life Assurance (Irl) plc managing asset allocation and various geographic equity portfolios, and has excellent knowledge and experience of capital markets and asset management. She has a B.A. Accounting and Finance and MSc. Investment and Treasury from Dublin City University. She is a fellow of the Institute of Chartered Accountants in Ireland, and a member of the Institute of Directors in Ireland. Éimear also has strong experience in the pharma manufacturing and controls environment as a non-executive Director of Chanelle Pharmaceuticals Group. Éimear is a non-executive Director on the Boards of Hostelworld Group plc where she chairs the Audit Committee and Yew Grove REIT plc.

 

Paul (47) is the Chairman and CEO of Tibidabo Scientific Industries Ltd, and was formerly the Chairman and CEO of Faxitron Bioptics LLC, leading it to its successful sale in 2018. He was also formerly the Chairman of Deerland Probiotics & Enzymes Inc. He has an excellent understanding of the US market and has significant experience in the global build out of a variety of medical and biotech businesses. Previously he worked in investment banking mergers & acquisitions at Merrill Lynch & Co. in New York and Sydney. He holds a BComm International from University College Dublin, and is a non-executive director of a number of private companies.

 

Neither Éimear Moloney nor Paul Murtagh hold any shares in the Company.

 

There are no disclosures required to be made pursuant to Rules 6.6.7 (2) to (6) of the Listing Rules.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDDBGBDGBI
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.